Delivery Order SPE2DB20D3103-SPE2DB24FM5P1
Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,687.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VISIPAQUE 320 MG/ML INFUS BTL 150ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML. The $1,687.64 order has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is a prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.56 contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a firm fixed price delivery order with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,109.55 contract is for the provision of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product, with a total ceiling value of $12,222.24 and a period of performance through March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, valued at $1,001.34 under a Firm Fixed Price contract type. The award was made on October 8, 2025, with an ultimate completion date of October 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, competitively awarded transaction under an existing contract vehicle and does not utilize...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The contract has a firm fixed price of $2,531.46 and a completion date of August 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these medical supplies to support the healthcare needs of military treatment facilities and other federal healthcare providers. This contract...
- This federal contract award, valued at $1,650.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order worth $1,383.12 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML pharmaceutical products. The contract has a final completion date of September 24, 2024 and uses a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $2,536.80 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100 ml bottles, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's Conshohocken,...